Literature DB >> 14614354

A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia.

Yuval Shilon1, Ariella Bar-Gil Shitrit, Bernard Rudensky, Amos M Yinnon, Maya Margalit, Jaqueline Sulkes, David Shitrit.   

Abstract

Previous research has shown a link between infectious inflammatory processes and hemostatic abnormalities. No data exist, however, on whether coagulation markers correlate with the severity of community-acquired pneumonia (CAP) at admission. We conducted a prospective, observational study in an Emergency Medicine Department of a primary care hospital. Sixty-eight patients admitted with CAP were included. Blood samples were collected at admission and assayed for D-dimer levels. D-dimers were correlated with the Pneumonia Patient Outcome Research Team (PORT) score and Acute Physiology and Chronic Health Evaluation II score on admission, with length of hospital stay, number of organ failures, time to defervescence and hospital mortality. D-dimer levels were positively correlated with the Acute Physiology and Chronic Health Evaluation II score (r = 0.44, P = 0.0002), the PORT score (r = 0.36, P = 0.002) and the length of hospital stay (r = 0.24, P = 0.046). Mean D-dimer levels of patients for whom hospitalization is recommended, according to PORT guidelines, were significantly higher than D-dimer levels of patients for whom hospitalization is not recommended (1.47 +/- 1.05 microg/ml and 0.71 +/- 0.79 microg/ml respectively; P = 0.006). The correlation between D-dimer levels and time to defervescence, development of organ system failure and outcome was not statistically significant. We conclude that D-dimer levels at admission may predict the severity of CAP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614354     DOI: 10.1097/00001721-200312000-00009

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  12 in total

1.  Elevated D-Dimer Levels are Associated with Increased Risk of Mortality in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Siddharth Shah; Kuldeep Shah; Siddharth B Patel; Foram S Patel; Mohammed Osman; Poonam Velagapudi; Mohit K Turagam; Dhanunjaya Lakkireddy; Jalaj Garg
Journal:  Cardiol Rev       Date:  2020-07-02       Impact factor: 2.644

2.  Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms.

Authors:  Ram S Duriseti; Margaret L Brandeau
Journal:  Ann Emerg Med       Date:  2010-06-03       Impact factor: 5.721

Review 3.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

4.  The association between plasma D-dimer levels and community-acquired pneumonia.

Authors:  Sulhattin Arslan; Serdal Ugurlu; Gokten Bulut; Ibrahim Akkurt
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

5.  Prevalence and significance of coagulation abnormalities in community-acquired pneumonia.

Authors:  Eric B Milbrandt; Michael C Reade; MinJae Lee; Stephanie L Shook; Derek C Angus; Lan Kong; Melinda Carter; Donald M Yealy; John A Kellum
Journal:  Mol Med       Date:  2009-09-08       Impact factor: 6.354

Review 6.  Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?

Authors:  Hiba Narvel; Anam Sayed; Nida Narvel; Shreyas Yakkali; Tasleem Katchi
Journal:  J Clin Med Res       Date:  2021-04-27

7.  A Pilot Study of the Performance Characteristics of the D-dimer in Presumed Sepsis.

Authors:  Phillip J Goebel; Justin B Williams; Robert T Gerhardt
Journal:  West J Emerg Med       Date:  2010-05

Review 8.  Biomarkers in community-acquired pneumonia: a state-of-the-art review.

Authors:  Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Sanvicente; Elyara F Pacheco; Karoline Dalla Rosa
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

Review 9.  D-Dimer elevation and adverse outcomes.

Authors:  Rim Halaby; Christopher J Popma; Ander Cohen; Gerald Chi; Marcelo Rodrigues Zacarkim; Gonzalo Romero; Samuel Z Goldhaber; Russell Hull; Adrian Hernandez; Robert Mentz; Robert Harrington; Gregory Lip; Frank Peacock; James Welker; Ignacio Martin-Loeches; Yazan Daaboul; Serge Korjian; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

10.  Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study.

Authors:  Jiao Liu; Sheng Zhang; Zhixiong Wu; You Shang; Xuan Dong; Guang Li; Lidi Zhang; Yizhu Chen; Xiaofei Ye; Hangxiang Du; Yongan Liu; Tao Wang; SiSi Huang; Limin Chen; Zhenliang Wen; Jieming Qu; Dechang Chen
Journal:  Ann Intensive Care       Date:  2020-07-31       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.